Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Dec 03, 2020 12:55am
122 Views
Post# 32024204

RE:RE:RE:Warrants

RE:RE:RE:Warrants

thanks for that info but I'm pretty sure they can't sell a half warrant so the $1.10 would be for a full warrant, am I correct? At .06 plus exercise price of  .09 currently so $1.2 vs $1.1 on the new offering. So if i could buy the new ones at .01-.02 each I would do better, that's what I'm trying to figure out



LithLover wrote:

I would be very careful with the warrants.  according to the prospectus the warrants are being offered as 1/2 warrants per share purchased not full warrants on the 2nd offering.

The current warrants don't have a lot of volume so they are not easy to trade. The other warrants couod be even less liquid.  This means you could be stuck selling for less if you need to sell

Unless you plan to hold to $3 or higher you would be better off in shares.  Warrants are also non voting and could be adjusted by the company. As well in the case of a buyout you would need to have the funds to exercise them. 

Look at today only $12k in warrants traded today to drop the price  -8%    Warrant trading is much more volitile and there is no guarantee the volume will be there when u might need to sell.

if you don't know much about warrants or plan to hold for multiple dollars stick to the shares.  
 

skiboard09 wrote: I'd be curious what ppl think as well ?
 

 

 



<< Previous
Bullboard Posts
Next >>